ViTToria Biotherapeutics Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
13
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$3.05M
- Investors
-
11
ViTToria Biotherapeutics General Information
Description
Operator of a gene-edited cell therapeutics company intended to deliver next-generation, paradigm-shifting T-cell therapies. The company's technology improves efficacy, enhances safety, and expands the utility of cell-based therapeutics by lowering dosing requirements, easing preconditioning regimens, reducing manufacturing failures, and shortening vein-to-vein times, enabling medical practitioners to improve patient outcomes.
Contact Information
Website
www.vittoriabio.comCorporate Office
- 3675 Market Street
- Suite 200
- Philadelphia, PA 19104
- United States
Corporate Office
- 3675 Market Street
- Suite 200
- Philadelphia, PA 19104
- United States
ViTToria Biotherapeutics Timeline
ViTToria Biotherapeutics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
4. Early Stage VC | 01-Jan-2024 | $3.05M | Completed | Pre-Clinical Trials | ||
3. Seed Round | Cancelled | Pre-Clinical Trials | ||||
2. Seed Round | 07-Jun-2022 | $10M | $10M | Completed | Pre-Clinical Trials | |
1. Accelerator/Incubator | 08-Feb-2022 | Completed | Stealth |
ViTToria Biotherapeutics Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Seed-2 | ||||||||
Seed-1 |
ViTToria Biotherapeutics Comparisons
Industry
Financing
Details
ViTToria Biotherapeutics Competitors (42)
One of ViTToria Biotherapeutics’s 42 competitors is Amphivena Therapeutics, a Venture Capital-Backed company based in South San Francisco, CA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Amphivena Therapeutics | Venture Capital-Backed | South San Francisco, CA | ||||
Noveome Biotherapeutics | Venture Capital-Backed | Pittsburgh, PA | ||||
Cidara Therapeutics | Formerly VC-backed | San Diego, CA | ||||
Gyre Therapeutics | Formerly VC-backed | San Diego, CA | ||||
Adimab | Venture Capital-Backed | Lebanon, NH |
ViTToria Biotherapeutics Signals
ViTToria Biotherapeutics Investors (11)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Ben Franklin Technology Partners of Southeastern Pennsylvania | Accelerator/Incubator | Minority | ||
BioAdvance | Venture Capital | Minority | ||
Global BioAccess Fund | Venture Capital | Minority | ||
Knollwood Investment Fund | Venture Capital | Minority | ||
Leukemia & Lymphoma Society | Not-For-Profit Venture Capital | Minority |
ViTToria Biotherapeutics FAQs
-
When was ViTToria Biotherapeutics founded?
ViTToria Biotherapeutics was founded in 2021.
-
Where is ViTToria Biotherapeutics headquartered?
ViTToria Biotherapeutics is headquartered in Philadelphia, PA.
-
What is the size of ViTToria Biotherapeutics?
ViTToria Biotherapeutics has 13 total employees.
-
What industry is ViTToria Biotherapeutics in?
ViTToria Biotherapeutics’s primary industry is Drug Discovery.
-
Is ViTToria Biotherapeutics a private or public company?
ViTToria Biotherapeutics is a Private company.
-
What is ViTToria Biotherapeutics’s current revenue?
The current revenue for ViTToria Biotherapeutics is
. -
How much funding has ViTToria Biotherapeutics raised over time?
ViTToria Biotherapeutics has raised $13M.
-
Who are ViTToria Biotherapeutics’s investors?
Ben Franklin Technology Partners of Southeastern Pennsylvania, BioAdvance, Global BioAccess Fund, Knollwood Investment Fund, and Leukemia & Lymphoma Society are 5 of 11 investors who have invested in ViTToria Biotherapeutics.
-
Who are ViTToria Biotherapeutics’s competitors?
Amphivena Therapeutics, Noveome Biotherapeutics, Cidara Therapeutics, Gyre Therapeutics, and Adimab are some of the 42 competitors of ViTToria Biotherapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »